Purdue Files ANDA Amid Global Bankruptcy Settlement Bid

Company Seeking To Become ‘Public Health Company’

 
• By Dean Rudge

Purdue Pharma has taken a step in its bid to develop and market generic versions of treatments to reverse opioid overdose “at or below cost,” following its filing for bankruptcy.

An ampoule Opioid next to it is a note written in English Opioid epidemic. All around, many tablets and syringes are scattered.
Purdue has priority review for nalmefene • Source: Shutterstock

More from Generics

More from Products